Table 5.
Serum concentrations of cardiovascular disease risk factors in the peritoneal dialysis patients classified according to sarcopenia and obesity
| Parameter | Sarcopenic obesity | Nonsarcopenic obesity | Sarcopenia & nonobesity | Nonsarcopenic & nonobesity |
|---|---|---|---|---|
| hs-CRP (mg/L) | 8.0 ± 0.3† | 6.8 ± 0.7† | 6.0 ± 1.4 | 4.3 ± 0.5 |
| sICAM-1 (ng/mL) | 251.0 ± 95.0 | 385.0 ± 29.0†,‡ | 180.0 ± 52.0 | 153.0 ± 17.0 |
| MDA (μmol/L) | 8.9 ± 0.2 | 5.2 ± 1.2 | 7.2 ± 2.0 | 7.0 ± 0.6 |
| Lp (a) (mg/dL) | 56.0 ± 2.0 | 62.0 ± 12.0 | 61.0 ± 17.0 | 58 ± 6.0 |
| Triglyceride (mg/dL) | 234.0 ± 61.0† | 185.0 ± 30.0† | 186.0 ± 28.0 | 150.0 ± 9.0 |
| Total cholesterol (mg/dL) | 220.0 ± 26.0 | 182.0 ± 26.0 | 154.0 ± 11.0 | 161.0 ± 5.0 |
| LDL-C (mg/dL) | 129.0 ± 13.0 | 110.0 ± 26.0 | 67.0 ± 8.5 | 86.0 ± 4.5 |
| HDL-C (mg/dL) | 45.0 ± 10.0 | 35.0 ± 2.0†,‡ | 50.0 ± 8.0 | 45.0 ± 2.0 |
Data are presented as mean ± standard error.
HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitive C-reactive protein; LDL-C, low-density lipoprotein cholesterol; Lp (a), lipoprotein (a); MDA, malondialdehyde; sICAM-1, soluble intercellular adhesion molecule type 1.
†
P < 0.05 versus nonsarcopenic & nonobesity;
‡
P < 0.05 versus sarcopenia & nonobesity.